Sionna Therapeutics, Inc./$SION
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Sionna Therapeutics, Inc.
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefits to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.
Ticker
$SION
Sector
Primary listing
Employees
59
Headquarters
Website
SION Metrics
BasicAdvanced
$1.6B
-
-$1.88
-
-
Price and volume
Market cap
$1.6B
52-week high
$45.00
52-week low
$7.26
Average daily volume
272K
Financial strength
Current ratio
20.613
Quick ratio
20.14
Long term debt to equity
2.414
Total debt to equity
2.828
Profitability
EBITDA (TTM)
-88.335
Management effectiveness
Return on assets (TTM)
-21.74%
Return on equity (TTM)
-31.79%
Valuation
Price to book
5.22
Price to tangible book (TTM)
5.22
Price to free cash flow (TTM)
-21.481
Free cash flow yield (TTM)
-4.66%
Free cash flow per share (TTM)
-1.668
Growth
Earnings per share change (TTM)
-88.22%
3-year earnings per share growth (CAGR)
-50.59%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Sionna Therapeutics, Inc. stock?
Sionna Therapeutics, Inc. (SION) has a market cap of $1.6B as of March 18, 2026.
What is the P/E ratio for Sionna Therapeutics, Inc. stock?
The price to earnings (P/E) ratio for Sionna Therapeutics, Inc. (SION) stock is 0 as of March 18, 2026.
Does Sionna Therapeutics, Inc. stock pay dividends?
No, Sionna Therapeutics, Inc. (SION) stock does not pay dividends to its shareholders as of March 18, 2026.
When is the next Sionna Therapeutics, Inc. dividend payment date?
Sionna Therapeutics, Inc. (SION) stock does not pay dividends to its shareholders.
What is the beta indicator for Sionna Therapeutics, Inc.?
Sionna Therapeutics, Inc. (SION) does not currently have a Beta indicator.